Chow JY, Estrema C, Orneles T, Dong X, Barrett KE, Dong H. Calcium-sensing receptor modulates extracellular Ca 2ϩ entry via TRPC-encoded receptor-operated channels in human aortic smooth muscle cells. Am J Physiol Cell Physiol 301: C461-C468, 2011. First published May 11, 2011; doi:10.1152/ajpcell.00389.2010.-Ca-sensing receptor (CaSR), a member of the G protein-coupled receptor family, regulates the synthesis of parathyroid hormone in response to changes in serum Ca 2ϩ concentrations. (4, 10, 17, 28) . Therefore, dysregulation of Ca 2ϩ homeostasis in the body results in pathological changes in different systems (4, 22, 25) . One of the regulators of Ca 2ϩ homeostasis is the plasma membrane Ca-sensing receptor (CaSR), which is a plasma membrane protein with 1,078 amino acids that was initially cloned from bovine parathyroid cells (5-7). CaSR is a member of the G protein-coupled receptor (GPCR) family and regulates the synthesis of parathyroid hormone (6, 8, 15 ) in response to changes in serum Ca 2ϩ concentrations. In addition, CaSR activation elicits complex intracellular signaling events through modulation of a wide range of intracellular mediators, including G proteins and phospholipase C (PLC). These, in turn, stimulate both protein kinase C (PKC) activation and inositol 1,4,5-trisphosphate (IP 3 ) production, the latter inducing intracellular Ca 2ϩ release (6, 15). Therefore, CaSR plays an important role in the regulation of serum Ca 2ϩ concentrations in the body and [Ca 2ϩ ] cyt homeostasis in mammalian cells. The plasma membrane CaSR can be directly activated by several CaSR agonists, such as extracellular Ca 2ϩ ([Ca 2ϩ ] o ) and spermine (6 -8, 14).
]cyt) in HASMC, with a half-maximal response (EC50) of 0.52 mM and a Hill coefficient of 5.50. CaSR was expressed in HASMC, and the [Ca 2ϩ ]o-induced [Ca 2ϩ ]cyt rise was abolished by dominant negative mutants of CaSR. The CaSR-mediated increase in [Ca 2ϩ ]cyt was also significantly inhibited by pertussis toxin, the phospholipase C inhibitor U-73122, or the general protein kinase C (PKC) inhibitor chelerythrine, but not by the conventional PKC inhibitor, Gö6976. Depletion of membrane cholesterol by pretreatment with methyl-␤-cyclodextrin markedly decreased CaSR-induced increase in [Ca 2ϩ ]cyt. Blockade of TRPC channels with 2-aminoethoxydiphenyl borate, SKF-96365, or La 3 significantly inhibited [Ca 2ϩ ]o entry, whereas activation of TRPC6 channels with flufenamic acid potentiated [Ca 2ϩ ]o entry. Neither cyclopiazonic acid nor caffeine or ionomycin had any effect on [Ca 2ϩ ]cyt in [Ca 2ϩ ]o-free solutions. TRPC6 and PKCε mRNA and proteins were detected in HASMC, and [Ca 2ϩ ]o induced PKCε phosphorylation, which could be prevented by chelerythrine. Our data suggest that CaSR activation mediates [Ca 2ϩ ]o entry, likely through TRPC6-encoded receptor-operated channels that are regulated by a PLC/PKCε cascade. Our study therefore provides evidence not only for functional expression of CaSR, but also for a novel pathway whereby it regulates [Ca 2ϩ ]o entry in HASMC.
Ca 2ϩ signaling; TRPC6 channels; PKCε phosphorylation; vascular smooth muscle cells CYTOSOLIC FREE Ca 2ϩ ([Ca 2ϩ ] cyt ) is known to play an essential role in various mammalian cells, regulating physiological functions such as neurotransmitter release, muscle contraction, fertilization, gene regulation, proliferation, and apoptosis (4, 10, 17, 28) . Therefore, dysregulation of Ca 2ϩ homeostasis in the body results in pathological changes in different systems (4, 22, 25) . One of the regulators of Ca 2ϩ homeostasis is the plasma membrane Ca-sensing receptor (CaSR), which is a plasma membrane protein with 1,078 amino acids that was initially cloned from bovine parathyroid cells (5) (6) (7) . CaSR is a member of the G protein-coupled receptor (GPCR) family and regulates the synthesis of parathyroid hormone (6, 8, 15) in response to changes in serum Ca 2ϩ concentrations. In addition, CaSR activation elicits complex intracellular signaling events through modulation of a wide range of intracellular mediators, including G proteins and phospholipase C (PLC). These, in turn, stimulate both protein kinase C (PKC) activation and inositol 1,4,5-trisphosphate (IP 3 ) production, the latter inducing intracellular Ca 2ϩ release (6, 15) . Therefore, CaSR plays an important role in the regulation of serum Ca 2ϩ concentrations in the body and [Ca 2ϩ ] cyt homeostasis in mammalian cells. The plasma membrane CaSR can be directly activated by several CaSR agonists, such as extracellular Ca 2ϩ ([Ca 2ϩ ] o ) and spermine (6 -8, 14) .
Although CaSR has been well documented to play important physiological roles in various types of mammalian cells, especially in parathyroid cells (6, 8, 15) , the knowledge of its expression and function in the human cardiovascular system is limited. Recently, growing evidence suggests that CaSR is expressed in vascular smooth muscle cells (VSMC), likely modulates arterial blood pressure, and mediates VSMC proliferation through the MEK1/ERK1/2 signaling pathway (21, 32) . However, the mechanism(s) whereby CaSR mediates physiological events in VSMC are not fully understood. Here, we sought to investigate the mechanisms underlying CaSR-mediated [Ca 2ϩ ] cyt signaling pathway in human aortic smooth muscle cells (HASMC) as a model of VSMC because CaSR is known to be functionally expressed in this cell type (21) .
MATERIALS AND METHODS
Cell culture. HASMC (ScienceCell Research Laboratories, San Diego, CA) were cultured in smooth muscle growth medium (SmGM, ScienceCell) at 37°C in a humidified 5% CO 2 plus 95% air atmosphere. SmGM was supplemented with 5% fetal bovine serum, 0.5 ng/ml human epidermal growth factor, 2 ng/ml human fibroblast growth factor, and 5 g/ml insulin. The medium was changed every 48 h thereafter and cells of passages 1-10 were used for experiments (21) .
Transfection of Flag-tagged dominant negative-CaSR constructs into HASMC. We used two CaSR dominant negative mutants that are mutated at different locations of the wild-type CaSR, R185Q and R795W (gifts of Dr. Edward Brown, Harvard University). Flag protein was also cloned into these mutants. R185Q is characterized by mutation of the ligand binding region of the wild-type CaSR, while R795W is characterized by mutation of the transmembrane region. Both R185Q and R795W had substantially attenuated responses to [Ca 2ϩ ]o although they exhibited normal patterns of receptor protein expression (1) . R185Q showed a prominent "dominant negative" effect on the coexpressed wildtype receptor, while R795W mutation could potentially still bind to its respective G protein(s) but fail to activate them. HASMC were transfected with the plasmid DNA constructs with Fugene 6. Six-well plates containing 80 -90% confluent cells in each well were transfected with a total of 2 g/well plasmid DNA. [Ca 2ϩ ]cyt measurement and membrane protein extraction for Western blots were performed 48 h after transfection.
[Ca 2ϩ ]cyt measurement. [Ca 2ϩ ]cyt levels in HASMC were measured by fura-2 fluorescence ratio digital imaging as described previously (36) . Briefly, HASMC were trypsinized and replated onto 10-mm round glass coverslips that had been precoated with 1 mg/ml poly-D-lysine (Sigma) at a density such that 70 -90% confluence was achieved within 24 h. They were then loaded with 5 M fura-2 acetoxymethyl ester (AM) [dissolved in 0.01% Pluronic F-127 plus 0.1% DMSO in normal physiological salt solution (PSS), described below] at room temperature for 50 min, then washed in PSS for at least 20 min. Thereafter, the coverslips with HASMC were mounted in a perfusion chamber on a Nikon microscope stage. Cells were initially superfused with PSS for 5 min and then switched to Ca 2ϩ -free or Ca 2ϩ solutions containing drugs of interest. Fura-2 fluorescence ratio (510-nm light emission excited by 340-or 380-nm illuminations), as well as background fluorescence, was collected at room temperature (22°C) with the use of a ϫ40 Nikon UV-Fluor objective and an intensified CCD camera (ICCD200 RT-PCR analysis of TRPC. Briefly, total RNA (5 g) from HASMC was extracted with TRIzol reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions and our previous publication (2) . RNA were converted into cDNA with reverse transcriptase and PCR was performed using the following primers: TRPC1 (accession no. NM_003304) forward strand, 5=-TGCTTAC-CAAACTGCTGGTG-3= and reverse strand, 5=-AACTGTTTTGC-CGTTTGACC-3=; TRPC3 (accession no. NM_003305) forward strand, 5=-CTTTCCTTCAGGCAACGAAG-3= and reverse strand, 5=-GTACG-CAATCCGAGAGAAGC-3=; TRPC4 (accession no. NM_016179) forward strand, 5=-GCTGGAGGAGAAGACACTGG-3= and reverse strand, 5=-GACCTGTCGATGTGCTGAGA-3=; and TRPC6 (accession no. NM_004621) forward strand, 5=-GCCAATGAGCATCTG-GAAAT-3= and reverse strand, 5=-AACCTCTTGCCTTCAGCAAA-3=. The conditions for PCR reactions for these genes were similar to those previously described (9) . Primers for GAPDH were used as a control (forward strand, 5=-ACCACAGTCCATGCCATCAC-3= and reverse strand, 5=-TCCACCACCCT-GTTGCTGTA-3=). The samples were amplified in an automated thermal cycler (GeneAmp 2400; Applied Biosystems). DNA amplification conditions included an initial 3-min denaturation step at 94°C, 35 cycles of 30 s at 94°C, 30 s at 57°C, 40 s at 72°C, and a final elongation step of 10 min at 72°C. The products were separated on a 1.5% agarose gel, stained with ethidium bromide, and then photographed under UV light.
Western blot analysis. HASMC cells were washed three times with ice-cold PBS. Cells were then lysed with total lysis buffer [150 mM NaCl, 10 mM Tris·HCl (pH 7.8), 1 mM EDTA, 0.5% Triton X-100, and 1 mM sodium orthovanadate] containing protease inhibitors (1 g/ml leupeptin and 100 g/ml PMSF) and incubated at 4°C for 30 min with constant shaking. The cells were then scraped into microcentrifuge tubes and centrifuged at 12,000 g for 15 min to remove insoluble material. The protein content in each sample was determined and normalized. Cell lysates were then resuspended in 2ϫ gel loading buffer, boiled for 5 min, and then separated by SDS-polyacrylamide gel electrophoresis (9% polyacrylamide). Resolved proteins were transferred overnight at 4°C onto a polyvinylidene difluoride membrane (Millipore, Billerica, MA). Membranes were then blocked with a 5% solution of skim milk for 30 min at room temperature, followed by further incubation with monoclonal antibodies specific for CaSR (1:1,000, Abcam, Cambridge, MA), TRPC1, -4, and -6 (1:500, Alomone Lab, Israel), phospho-PKCε 1:1,000 (Upstate Biotechnology, Lake Placid, NY), PKC␣ 1:1,000 (BD Biosciences, San Jose, CA), or GAPDH 1:5,000 (Ambion, Austin, TX). After being washed with PBS with 1% Tween (PBST), the rabbit anti-mouse secondary antibody was applied to the membrane. After washing with PBST, the membrane was treated with a chemiluminescent solution (Fivephoton Biochemicals, San Diego, CA) according to manufacturer's instructions and exposed to X-ray film. Densitometric analysis of the blots was performed with the use of an AlphaImager digital imaging system (Alpha Innotech, San Leandro, CA).
Chemicals and solutions. SKF-96365, U-73122, nifedipine, chelerythrine, and Gö6976 were purchased from Sigma. 2-Aminoethoxydiphenyl borate (2-APB) was purchased from Tocris Bioscience (Ellisville, MO). Chiral enantiomers of BEL (S-and R-BEL) were from Cayman Chemical (Ann Arbor, MI). Fura 2-AM was from Molecular Probes (Eugene, OR). The other chemicals were obtained from Fisher Scientific (Santa Clara, CA).
Statistical analysis. Results are expressed as means Ϯ SE. Differences between means were considered to be statistically significant at P Ͻ 0.05 using Student's t-test or one-way ANOVA followed by Newman-Keuls post hoc test, as appropriate. (Fig. 1A) . CaSR activation appeared to be cooperative, with a steep dose-response relationship (Fig. 1B) (26), or may even directly leak into unhealthy cells through nonspecific pathways. We therefore tested these possibilities using spermine, another direct activator of CaSR (6, 21) . While spermine at 1 mM did not affect the basal [Ca 2ϩ ] cyt in normal PSS, obvious increases were seen at 3 mM (Fig. 1C) . In addition, spermine (3 mM) did not affect the basal [Ca 2ϩ ] cyt in Ca 2ϩ -free PSS, but significantly increased [Ca 2ϩ ] cyt in normal Ca 2ϩ PSS (Fig. 1D) . These results provide further evidence for a functional role of CaSR in the regulation of [Ca 2ϩ ] cyt in HASMC. To demonstrate the presence of CaSR in HASMC, we performed Western blot analysis of lysates from HASMC and HT29, a human colonic cancer cell line used as a positive control. HASMC lysate produced a band of 160 kDa ( Fig. 2A) , consistent with the mature, full-size CaSR (21) . To confirm the functional role of CaSR in the regula-tion of [Ca 2ϩ ] cyt in HASMC, we used the CaSR mutants R185Q and R795W. The former showed a prominent dominant negative effect on the coexpressed wild-type receptor, while the latter could potentially still bind to its respective G protein(s) but fail to activate them (1). After transfection of dominant negative-CaSR constructs in HASMC for 48 h, expression of Flag-R185Q and Flag-R795W, but not empty (MT) vector, was seen (Fig. 2B) (6, 15) . Therefore, we sought to test the involvement of these pathways following CaSR activation in HASMC, using [Ca 2ϩ ] o at both the threshold concentration (0.5 mM) and maximal concentration (1.0 mM). We first examined whether CaSR activation stimulates G proteins. HASMC were superfused with [Ca 2ϩ ] o with or without pertussis toxin (PTX, 100 ng/ml) (Fig. 3A) , a G i/0 protein inhibitor (37) . PTX significantly reduced the [Ca 2ϩ ] o -induced Ca 2ϩ signal (Fig. 3B) . We next investigated the role of PLC using a selective PLC inhibitor (20) , U-73122 (30 M) (Fig. 3C ).
RESULTS

CaSR activation induces
As shown in Fig. 3, C and D ] o . Taken together, both G proteins and PLC are involved in CaSR-mediated Ca 2ϩ signaling in HASMC, which is consistent with other reports (5, 11) .
To test whether CaSR activation stimulates PKC, HASMC were superfused with [Ca 2ϩ ] o in the absence (Fig. 4A) or the presence of chelerythrine (10 M) (Fig. 4B) , an inhibitor of the majority of PKC isoforms (39), or Gö6976 (10 M) (Fig. 4C) , a relatively selective inhibitor for conventional isoforms of PKC (39) . As shown in Fig. 4D signaling. More than 11 isoforms of PKC have been identified (23) . To further our understanding of the expression of different isoforms of PKC in HASMC, we screened for expression of PKC isoforms using Western blot analysis of whole cell lysates. Like BxPc3 cells, pancreatic ductal cells that were used as positive controls (9), HASMC contained proteins immunoreactive with antibodies to PKC␣, -␤, and -␥ in the conventional family, PKCε, -, and -␦ in the novel family, and PKC in the atypical family (Fig. 5) . Since PKCε was previously implicated in the regulation of Ca 2ϩ signaling in rabbit aortic smooth muscle cells (23), we focused on PKCε phosphorylation in HASMC in response to CaSR activation. As shown in Fig. 6 , PMA (1 M)-induced serine phosphorylation of PKCε in HASMC was reversed by chelerythrine (10 M). Similarly, [Ca 2ϩ ] o -induced (0.5 mM) PKCε serine phosphorylation was also prevented by chelerythrine (10 M) (Fig. 6) , suggesting that CaSR activation results in PKCε phosphorylation in HASMC (35) .
Source of Ca 2ϩ mobilized by CaSR activation. Since GPCR activation may mobilize different Ca 2ϩ sources in different cell types, we investigated whether CaSR activation induces intra- ] o induced significant [Ca 2ϩ ] cyt signaling in HASMC (Fig. 7, A, C, and  D) . Interestingly, re-addition of [Ca 2ϩ ] o after application of CPA plus caffeine did not induce a significant [Ca 2ϩ ] cyt increase in HASMC (Fig. 7, B vs. A) (Fig. 9) .
We then examined the expression of TRPC channels in HASMC. Our RT-PCR data revealed transcripts for TRPC1, -3, -4, and -6 in HASMC (Fig. 9E) , and Western blotting identified protein expression of TRPC1 and -6 (Fig. 9F) . These data further support that TRPC-encoded NSCC may contribute to CaSR-mediated Ca 2ϩ entry in HASMC.
Caveolae are involved in CaSR-mediated Ca 2ϩ signaling. Spatially organized complexes of signaling molecules, such as caveolae, were found recently in microdomains of the plasma membrane in VSMC (13) . These are important microstructures within the plasma membrane that contain signaling molecules such as caveolins, GPCR, and TRPC, all of which are involved in multiple cellular processes including Ca 2ϩ homeostasis and signal transduction (27) . Since caveolae are enriched in cholesterol, we tested whether caveolae were involved in CaSR-mediated Ca 2ϩ entry by pretreating HASMC with M␤CD (5 mM) for 1 h to deplete membrane cholesterol (27) . Indeed, M␤CD decreased CaSR-mediated Ca 2ϩ entry in HASMC (Fig. 10) Although CaSR was cloned from and characterized in bovine parathyroid cells in 1993 (5), it was recently shown also to be expressed in human VSMC and to function via the ERK signaling pathway (21) . However, the proximal mechanism(s) by which CaSR transduces calcium-dependent signaling in VSMC are largely unknown. CaSR has physiological roles in the cardiovascular system by modulating myogenic tone in small arteries (24) , arterial blood pressure (12, 34) , and VSMC proliferation (32), through Ca 2ϩ and/or ERK1/2 pathways (21, 32). In the present study, we found that both [Ca 2ϩ ] o and spermine, two direct CaSR agonists with different molecular structures (33, 34) ] cyt in HASMC. Similar to other GPCR, CaSR activation stimulates PLC, which cleaves phosphatidylinositol 4,5-bisphosphate into 1,2-diacylglycerol (DAG) and IP 3 (6, 8, 33, 34) . While DAG activates PKCε, and Ca 2ϩ entry via receptor-operated calcium channels (ROC) (19, 29, 35, 38) , IP 3 causes intracellular Ca 2ϩ release from S/ER stores and depletion of intracellular Ca 2ϩ stores leads to Ca 2ϩ entry via store-operated calcium channels (SOC) in different cell types (26, 30) .
Both [Ca 2ϩ ] o and [Ca 2ϩ ] cyt play essential roles in numerous physiological process (10) . [Ca 2ϩ ] o is controlled by a complex homeostatic system, including the parathyroid glands and calcitonin-secreting C cells of various organs (6) . In resting conditions, little or no Ca 2ϩ crosses the plasma membrane passively, so as to maintain an almost 20,000-fold concentration gradient between [Ca 2ϩ ] cyt (ϳ100 nM) and [Ca 2ϩ ] o (ϳ1.2 mM) (6, 10) . This is coordinated by activity of membrane ion channels, Ca 2ϩ pumps, Na ] cyt homeostasis in VSMC were largely unknown. After excluding the involvement of VGCC, we focused on SOC and ROC, both of which exist in VSMC. The major differences between SOC and ROC are 1) SOC is known to be functionally activated by depletion of intracellular Ca 2ϩ stores, but ROC is activated via a PLC/PKCε cascade (19, 29, 35, 38) ; and 2) TRPC1 is a molecular candidate for SOC in VSMC, compared with TRPC6 for ROC (16, 19, 29, 38 
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